Misiu and Ohm and other science-minded others, her
Post# of 152556
(Total Views: 341)
Posted On: 05/07/2025 11:15:48 PM
Misiu and Ohm and other science-minded others, here's a question that will be pure speculation. But given our data, I'm sure there's a lot of speculating going on.
So, given Leronlimab was called into service as the 4th line of defense,
and given many of our patients received less than 700 mg -
Could we make an educated guess on what the expected outcomes would be if we were 1st line treatment at 700 mg?
Given LL is so safe, I assume this efficacy estimate will be what drives any partnership talks.
So, given Leronlimab was called into service as the 4th line of defense,
and given many of our patients received less than 700 mg -
Could we make an educated guess on what the expected outcomes would be if we were 1st line treatment at 700 mg?
Given LL is so safe, I assume this efficacy estimate will be what drives any partnership talks.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼